IRIS Accounts Production v24.3.2.46 12845735 Board of Directors 1.4.23 31.3.24 31.3.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128457352023-03-31128457352024-03-31128457352023-04-012024-03-31128457352022-03-31128457352022-04-012023-03-31128457352023-03-3112845735ns15:EnglandWales2023-04-012024-03-3112845735ns14:PoundSterling2023-04-012024-03-3112845735ns10:Director12023-04-012024-03-3112845735ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3112845735ns10:SmallEntities2023-04-012024-03-3112845735ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3112845735ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3112845735ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3112845735ns10:FullAccounts2023-04-012024-03-3112845735ns10:OrdinaryShareClass12023-04-012024-03-3112845735ns10:Director22023-04-012024-03-3112845735ns10:RegisteredOffice2023-04-012024-03-3112845735ns5:CurrentFinancialInstruments2024-03-3112845735ns5:CurrentFinancialInstruments2023-03-3112845735ns5:ShareCapital2024-03-3112845735ns5:ShareCapital2023-03-3112845735ns5:RetainedEarningsAccumulatedLosses2024-03-3112845735ns5:RetainedEarningsAccumulatedLosses2023-03-3112845735ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3112845735ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3112845735ns10:OrdinaryShareClass12024-03-31
REGISTERED NUMBER: 12845735 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

ALPHA BIOLABORATORIES COVID-19 TESTING
LIMITED

ALPHA BIOLABORATORIES COVID-19 TESTING
LIMITED (REGISTERED NUMBER: 12845735)

CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ALPHA BIOLABORATORIES COVID-19 TESTING
LIMITED

COMPANY INFORMATION
for the Year Ended 31 March 2024







DIRECTORS: Mr D Thomas
Ms R Thomas





REGISTERED OFFICE: 14 Webster Court
Carina Park
Westbrook
Warrington
WA5 8WD





REGISTERED NUMBER: 12845735 (England and Wales)





ACCOUNTANTS: Xeinadin
100 Barbirolli Square
Manchester
M2 3BD

ALPHA BIOLABORATORIES COVID-19 TESTING
LIMITED (REGISTERED NUMBER: 12845735)

BALANCE SHEET
31 March 2024

31.3.24 31.3.23
Notes £    £   
CURRENT ASSETS
Debtors 4 880,761 881,121

CREDITORS
Amounts falling due within one year 5 182,483 182,139
NET CURRENT ASSETS 698,278 698,982
TOTAL ASSETS LESS CURRENT LIABILITIES 698,278 698,982

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings 698,178 698,882
SHAREHOLDERS' FUNDS 698,278 698,982

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 March 2025 and were signed on its behalf by:





Mr D Thomas - Director


ALPHA BIOLABORATORIES COVID-19 TESTING
LIMITED (REGISTERED NUMBER: 12845735)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024


1. STATUTORY INFORMATION

Alpha Biolaboratories Covid-19 Testing Limited is a private company, limited by share capital, incorporated in England and Wales, registration number 12845735. The address of the registered office and principal place of business is Unit 14 Webster Court, Carina Park, Westbrook, Warrington, WA5 8WD.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Other debtors
Other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases, other debtors are stated at cost less impairment losses for bad and doubtful debts.

Other creditors
Other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method unless the effect of discounting would be immaterial, in which case they are stated at cost.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Other debtors 880,761 881,121

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Other creditors 182,483 182,139

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
100 Ordinary £1.00 100 100

7. RELATED PARTY DISCLOSURES

At the balance sheet date the business owed £182,483 (2023: £181,040) to companies under common control.

At the balance sheet date the business was owed £880,421 (2023: £118,746) from companies under common control.

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party are the directors of the business by virtue of their controlling interest in the business.